Companies Reporting Before The Bell
• Jerash Holdings (US) JRSH is projected to report quarterly earnings at $0.07 per share on revenue of $30.14 million.
• Redhill Biopharma RDHL is estimated to report quarterly loss at $0.23 per share on revenue of $24.30 million.
• View VIEW is likely to report quarterly loss at $0.24 per share on revenue of $15.10 million.
• LightInTheBox Holding LITB is likely to report earnings for its first quarter.
• Methode Electronics MEI is estimated to report quarterly earnings at $0.56 per share on revenue of $289.48 million.
• Darden Restaurants DRI is likely to report quarterly earnings at $2.21 per share on revenue of $2.54 billion.
• Accenture ACN is likely to report quarterly earnings at $2.74 per share on revenue of $15.35 billion.
• GMS GMS is likely to report quarterly earnings at $1.88 per share on revenue of $1.26 billion.
• Apogee Enterprises APOG is estimated to report quarterly earnings at $0.56 per share on revenue of $328.59 million.
• FactSet Research Systems FDS is estimated to report quarterly earnings at $3.23 per share on revenue of $473.08 million.
• Rite Aid RAD is likely to report quarterly loss at $0.70 per share on revenue of $5.75 billion.
Companies Reporting After The Bell
• VistaGen Therapeutics VTGN is estimated to report quarterly loss at $0.06 per share on revenue of $350.00 thousand.
• BlackBerry BB is projected to report quarterly loss at $0.07 per share on revenue of $205.62 million.
• Energy Transfer ET is likely to report quarterly earnings at $0.17 per share on revenue of $104.72 million.
• Smith & Wesson Brands SWBI is projected to report quarterly earnings at $0.69 per share on revenue of $179.85 million.
• CalAmp CAMP is likely to report quarterly loss at $0.03 per share on revenue of $69.43 million.
• FedEx FDX is likely to report quarterly earnings at $6.87 per share on revenue of $24.57 billion.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.